Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering

Cell Reports(2021)10.1016/j.celrep.2021.109207Source: DataRank Database

Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering is a research paper published in Cell Reports (2021). On theSindex it has a DataRank of 0. It has been cited 210 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access210 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)OA: goldTopics (41)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Connor A. Tsuchida ORCID,David N. Nguyen ORCID,Brian R. Shy ORCID,E. Riley McGarrigle ORCID,Cindy R. Sandoval Espinoza ORCID

Live enrichment

PubMed:34077734

NIH

Grant: U01AI142817-02

NIH

Grant: RM1HG009490

Sandia National Laboratories

Grant: 2101705

Sandia National Laboratories

Grant: 1655264

Deutsche Forschungsgemeinschaft

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5U01AI142817-04

Expanding CRISPR-Cas editing technology through exploration of novel Cas proteins and DNA repair systems

National Institutes of Health

Grant: 2RM1HG009490-06

Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease

National Institutes of Health

Grant: 5K08AI153767-04

CRISPR Editing of Primary Human Cells to Model and Correct Primary Immunodeficiency Mutations

goldLicense: CC BY NC ND

publisherhttp://www.cell.com/article/S2211124721005568/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124721005568?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124721005568?httpAccept=text/plain

repositoryhttps://www.osti.gov/biblio/1785401

repositoryhttps://www.osti.gov/biblio/1816032

Fields of Study

0301 basic medicine03 medical and health sciences0303 health sciences

Keywords

CD4-Positive T-LymphocytesCAR-T cellsMedical Physiology610Bioengineeringvirus-like particlesCRISPR deliveryArticleenv Gene ProductsJurkat CellsCRISPR-Associated Protein 9Receptorsviral engineeringGeneticsHumansprecision genome editingTransgenesCell EngineeringGene EditingReceptors, Chimeric Antigen5.2 Cellular and gene therapiesLentivirusGene Transfer TechniquesVirionenv Gene Products, Human Immunodeficiency VirusChimeric AntigenGene TherapyBiological SciencesQuality EducationRibonucleoproteinsA549 CellsHIV-1ImmunotherapyBiochemistry and Cell BiologyCRISPR-Cas9CRISPR-Cas SystemsHuman Immunodeficiency VirusBiotechnology

Sustainable Development Goals

SDG 3: 3. Good health